BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25867327)

  • 1. Clinical significance of lymphatic vessel invasion in stage I non-small cell lung cancer patients.
    Ma KF; Chu XY; Liu Y
    Genet Mol Res; 2015 Mar; 14(1):1819-27. PubMed ID: 25867327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma.
    Funai K; Sugimura H; Morita T; Shundo Y; Shimizu K; Shiiya N
    Ann Surg Oncol; 2011 Oct; 18(10):2968-72. PubMed ID: 21512862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival.
    Bréchot JM; Chevret S; Charpentier MC; Appere de Vecchi C; Capron F; Prudent J; Rochemaure J; Chastang C
    Cancer; 1996 Nov; 78(10):2111-8. PubMed ID: 8918404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral lymphatic vessel involvement is an invasive indicator of completely resected pathologic stage I non-small cell lung cancer.
    Harada M; Hato T; Horio H
    J Thorac Oncol; 2011 Jan; 6(1):48-54. PubMed ID: 21079523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic vessel invasion in pathologic stage I and II non-small cell lung tumors.
    Jeon HW; Kim KS; Kim YD; Jo KH; Park HJ; Wang YP; Park JK
    Surg Today; 2015 Aug; 45(8):1018-24. PubMed ID: 25424778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of vascular and lymphovascular invasion in early lung cancer.
    Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ
    Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract.
    Kikuchi E; Horiguchi Y; Nakashima J; Hatakeyama N; Matsumoto M; Nishiyama T; Murai M
    J Urol; 2005 Dec; 174(6):2120-3; discussion 2124. PubMed ID: 16280740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
    Zhang Y; Yan M; He J; Sun J; Sun X
    J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.
    Nentwich MF; Bohn BA; Uzunoglu FG; Reeh M; Quaas A; Grob TJ; Perez D; Kutup A; Bockhorn M; Izbicki JR; Vashist YK
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D2-40-positive lymphatic vessel invasion is not a poor prognostic factor in stage I lung adenocarcinoma.
    Shimizu K; Funai K; Sugimura H; Sekihara K; Kawase A; Shiiya N
    Pathol Int; 2013 Apr; 63(4):201-5. PubMed ID: 23692420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
    Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
    Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis.
    Wang J; Wang B; Zhao W; Guo Y; Chen H; Chu H; Liang X; Bi J
    PLoS One; 2012; 7(12):e52704. PubMed ID: 23285161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
    Akao J; Matsuyama H; Yamamoto Y; Hara T; Kawai Y; Sakano S; Ohmi C; Gondo T; Naito K
    BJU Int; 2008 Aug; 102(5):572-5. PubMed ID: 18485032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic analysis of curative surgery for stage IIIA-N2 non-small cell lung cancer].
    Liu JW; Li J; Lin G; Shang XQ
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):50-3. PubMed ID: 23648301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases.
    Barresi V; Reggiani Bonetti L; Vitarelli E; Di Gregorio C; Ponz de Leon M; Barresi G
    Am J Surg Pathol; 2012 Jan; 36(1):66-72. PubMed ID: 21989343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of lymphovascular invasion for patients with stage I non-small cell lung cancer.
    Hanagiri T; Takenaka M; Oka S; Shigematsu Y; Nagata Y; Shimokawa H; Uramoto H; Yamada S; Tanaka F
    Eur Surg Res; 2011; 47(4):211-7. PubMed ID: 22025080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.